IMDEX LIMITED (IMD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IMD

IMD - IMDEX LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: 0.81
Index: ASX200 | ASX300 | ALL-ORDS

Imdex is an Australian mining tech company. It manufacturers & provides drilling fluids, chemicals, mining instumentation and data & geo-analytical services. Formed in 1980, it became a listed company in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.09

25 Jun
2026

-0.110

OPEN

$4.13

-2.62%

HIGH

$4.14

824,413

LOW

$4.04

TARGET
$5.083

+0.12 change from previous day

24.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . DNL . DOW . EHL . GNG . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . SGH . SRG . SXE . TEA . VBC . XRF .
FNARENA'S MARKET CONSENSUS FORECASTS
IMD: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 15.5 13.7 xxx
DPS (cps) xxx 3.4 3.8 xxx
EPS Growth xxx 44.0% - 11.5% xxx
DPS Growth xxx 36.0% 9.3% xxx
PE Ratio xxx N/A 24.5 xxx
Dividend Yield xxx N/A 1.1% xxx
Div Pay Ratio(%) xxx 22.2% 27.4% xxx

Dividend yield today if purchased 3 years ago: 2.29%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.02

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 16/09 - ex-div 1.75c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx15.5
DPS All xxxxxxxxxxxxxxx3.4
Sales/Revenue xxxxxxxxxxxxxxx520.1 M
Book Value Per Share xxxxxxxxxxxxxxx133.6
Net Operating Cash Flow xxxxxxxxxxxxxxx126.0 M
Net Profit Margin xxxxxxxxxxxxxxx15.27 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx12.10 %
Return on Invested Capital xxxxxxxxxxxxxxx9.45 %
Return on Assets xxxxxxxxxxxxxxx8.10 %
Return on Equity xxxxxxxxxxxxxxx12.10 %
Return on Total Capital xxxxxxxxxxxxxxx9.91 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx56.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx9 M
Long Term Debt xxxxxxxxxxxxxxx275 M
Total Debt xxxxxxxxxxxxxxx284 M
Goodwill - Gross xxxxxxxxxxxxxxx525 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx41 M
Price To Book Value xxxxxxxxxxxxxxx3.07

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx69.3 M
Capex % of Sales xxxxxxxxxxxxxxx13.33 %
Cost of Goods Sold xxxxxxxxxxxxxxx362 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx74 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

07/05/2026

1

Buy

$5.15

25.92%

UBS remains upbeat on Imdex and the ongoing generation of double digit revenue growth in 4Q26 post the robust March quarter trading update.

Elevated exploration activity, growing penetration of customer spending and increasing contribution from higher-margin Digital offerings should underpin a strong run into fiscal year end.

FY26 revenue is forecast at $518m, implying 24% 4Q growth on the prior corresponding period, despite ongoing foreign exchange headwinds, while FY27 revenue is projected to rise to $602m as junior exploration activity recovers further.

The analyst expects 2H26 margins to soften modestly due to acquisition integration costs and investment spending, although views current margin levels as a likely floor given the stronger growth trajectory of sensors and Digital products.

EBITDA margins are forecast to improve progressively through FY27 and FY28, with upside risk to forecasts if higher-margin product growth continues to accelerate.

Buy rating retained. Target price rises to $5.15 from $4.70. UBS points to strong exploration trends, expanding technology adoption and Imdex's market leadership position.

FORECAST
UBS forecasts a full year FY26 dividend of 3.00 cents and EPS of 13.00 cents.
UBS forecasts a full year FY27 dividend of 4.00 cents and EPS of 15.00 cents.

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

11/05/2026

5

Downgrade to Sell from Underweight

$3.60

-11.98%

Jarden downgrades Imdex to a Sell rating from Underweight and maintains a $3.60 target price following a third-quarter trading update.

The company reported unaudited revenue of $123m for the period, representing 29% constant currency growth, yet the broker notes quarter-on-quarter revenue momentum appears to be flattening.

Commentary states consensus estimates imply a steep hurdle for the final quarter requiring 26% year-on-year revenue growth, leaving no room for execution missteps given the stock trades on an extreme forward price-earnings multiple of 31x.

Higher anticipated finance costs of -$12m to -$14m prompt the report to lower earnings per share forecasts to 10.2c from 10.3c in FY26, and to 11.4c from 11.5c in FY27.

While the underlying business is well managed within a robust industry environment, the broker finds extreme valuation multiples relative to historical averages offer little near-term support for the share price.

FORECAST
Jarden forecasts a full year FY26 dividend of 2.80 cents and EPS of 10.20 cents.
Jarden forecasts a full year FY27 dividend of 3.30 cents and EPS of 11.40 cents.

IMD STOCK CHART